Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02095756 · ClinicalTrials.gov registry record · NA
Combination Alexandrite Laser and Topical Therapy vs Topical Therapy Alone for Treatment of Melasma
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02095756: Completed NA study, sponsored by Cynosure.
NCT02095756 is a NA study that has completed, run by Cynosure. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02095756, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and safety of a combination of non-hydroquinone topical therapy and a 755nm Alexandrite compared to topical therapy alone for the treatment of facial melasma.
Primary Outcome
Evaluate the efficacy of a combination of non-hydroquinone topical therapy and a 755-nm alexandrite laser compared to topical therapy alone in the treatment of melasma .
Interventions
- OTHER 755nm Alexandrite Laser and Lytera Skin Brightening System (Non-Hydroquinone Topical Therapy)
- OTHER Lytera Skin Brightening System (Non-hydroquinone topical therapy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-06 |
| Phase | NA |
What the finished NCT02095756 record still lists
NCT02095756 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which 755nm Alexandrite Laser and Lytera Skin Brightening System (Non-Hydroquinone Topical Therapy) is the first listed.
NCT02095756 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02095756 about?
NCT02095756 is a clinical study titled "Combination Alexandrite Laser and Topical Therapy vs Topical Therapy Alone for Treatment of Melasma". The purpose of this study is to evaluate the efficacy and safety of a combination of non-hydroquinone topical therapy and a 755nm Alexandrite compared to topical therapy alone for the treatment of facial melasma.
What is the current status of trial NCT02095756?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-06. Estimated completion is 2014-06.
What interventions are being tested in trial NCT02095756?
The interventions under investigation include: 755nm Alexandrite Laser and Lytera Skin Brightening System (Non-Hydroquinone Topical Therapy) (OTHER), Lytera Skin Brightening System (Non-hydroquinone topical therapy) (OTHER).
Who is sponsoring clinical trial NCT02095756?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02095756's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia